October 29 is World Stroke Day. You can learn more about steps you can take to prevent a stroke at World Stroke Day, October 29, 2010. Professor Bo Norrving, president of the sponsoring World Stroke Organization, is a member of our StopAfib.org Medical Advisory Board.
Read MoreArchives
The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa …
Read MoreAn FDA panel today unanimously recommended that the FDA approve dabigatran (Pradaxa) for reducing the risk of afib strokes. FDA approval is expected quickly, making this the first alternative to warfarin approved in the United States, and also the first atrial fibrillation approval for dabigatran. It is approved in over 70 countries for venous thromboembolisms …
Read More